Predicting Prognosis in CPEO With mtDNA Deletions: A Case Demonstrating the Advantages of Measuring Heteroplasmy With Novel Droplet Digital Polymerase Chain Reaction Testing.
Document Type
Article
Publication Date
12-1-2023
Publication Title
Journal of neuro-ophthalmology
Volume
43
Issue
4
First Page
e260
Last Page
e263
Recommended Citation
Lambert-Cheatham NA, Tessema ST, Subei O, Sakuru RC, Fullmer MD, Selner EM, et al Predicting prognosis in CPEO with mtDNA deletions: a case demonstrating the advantages of measuring heteroplasmy with novel droplet digital polymerase chain reaction testing. J Neuroophthalmol. 2023 Dec 1;43(4):e260-e263. doi: 10.1097/WNO.0000000000001555. PMID: 35483062.
DOI
10.1097/WNO.0000000000001555
ISSN
1536-5166
PubMed ID
35483062
COinS